Epizyme (EPZM) Misses Q1 EPS by 71c
Tweet
Share
E-mailGet Alerts EPZM Hot Sheet
Join SI Premium – FREE
Epizyme (NASDAQ: EPZM) reported Q1 EPS of ($1.75), $0.71 worse than the analyst estimate of ($1.04). Revenue for the quarter came in at $911 thousand versus the consensus estimate of $5.63 thousand.
For earnings history and earnings-related data on Epizyme (EPZM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Associated Banc-Corp (ASB) Tops Q1 EPS by 3c
- South Plains Financial Inc. (SPFI) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
